CD38 and HIV infectious disease: Sampah et al. showed that MPA decreased HIV infection of blood CD4+ T cells, and that this was not associated with decreased levels of activation markers (CD25, CD69, CD38) or the (co)-receptors CD4, CCR5, or CXCR451.